Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone dosing and postoperative inflammation in esophagectomy
ChiCTR2500109536Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Highest serum C-reactive protein (CRP) within 3 days after surgery. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on ChiCTR2500109536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109536.